In prostate centers of the Governing Body of German Prostate Centers (DVPZ, Dachverband der Prostatazentren Deutschlands e.V.) treatment data from 3 university clinics, 21 treatment clinics, 3 private clinics and 330 general practitioners incorporated under 22 certificates are collated, in order to document the quality and type of cross-sectoral and interdisciplinary treatment, in particular of prostate cancer (PCA) patients.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
This analysis is based on the DVPZ UroCloud data sets from 20 July 2015. The UroCloud reflects the web-based chronological disease development and quality parameters. For the descriptive analysis of particular key figures, available complete data sets were selected.
Of the centers 22 held a valid certificate and fulfilled all required case numbers and structural prerequisites at the primary certification or recertification. In three cases a reauditing led to requirements before certification. Since 2005 a total of 9650 PCA patients have been pseudonymized and followed up (41,247 follow-up forms, 4. 3 forms per patient). In 2014 the median number of newly documented PCA patients was 61 per center (minimum 7 and maximum 295). Radical prostatectomy (RP) dominated with 4491 (56 %) cases followed by primary hormonal therapy (1210 cases, 15 %), irradiation (809, 10 %) and non-interventional therapy, such as active surveillance (AS) or watchful waiting (WW) in 760 cases (10 %). A prostate-specific antigen (PSA) reduction was documented in 50 % of the patients with a preoperative PSA value > 20, in 60 % of pT4 tumors and in 50 % of patients with a tumor Gleason score of 9-10. A positive incision margin (R+) was found in in 15 % of pT2 stages, 41 % of pT3 stages and 85 % of pT4 stages. A secondary intervention was documented in 6. 5 % of RP.
The DVPZ certificate reflects the complete spectrum of treatment of PCA patients. The strength of the certificate lies in the documentation of patient development and a simultaneous collation of quality parameters.
Der Urologe. Ausg. A. 2015 Nov 01 [Epub ahead of print]
R Berges, T Ebert, W Schafhauser, W Schultze-Seemann, M Braun, J Herden, P Weib, M Garcia Schürmann, M Reimann, C Bornhof, F Oberpenning, P Baur, J Zumbé, E Gronau, W Diederichs, O A Brinkman, M Goepel, A Göll, K Hoefner, M Kriegmair, S Laabs, B Planz, G Platz, A Heidenreich
PZ Köln (Campus Longerich, Campus Universitätsklinikum), Köln, Deutschland. PZ Metropolregion Nürnberg, Nürnberg, Deutschland. , PZ Hochfranken-Fichtelgebirge, Marktredwitz, Deutschland. , PZ Freiburg, Freiburg, Deutschland. , PZ Köln (Campus Longerich, Campus Universitätsklinikum), Köln, Deutschland. , PZ Köln (Campus Longerich, Campus Universitätsklinikum), Köln, Deutschland. , Kompetenznetz Prostata Siegen, Siegen, Deutschland. , PZ Niederrhein, Wesel, Deutschland. , PZ Moers, Moers, Deutschland. , PZ Nürnberg-Mittelfranken, Nürnberg, Deutschland. , PZ Bocholt, Bocholt, Deutschland. , PZ Nymphenburg, München, Deutschland. , PZ Leverkusen, Leverkusen, Deutschland. , PZ Münsterland, Münster, Deutschland. , Berliner PZ, Berlin, Deutschland. , PZ Emsland, Lingen, Deutschland. , PZ West, Velbert, Deutschland. , PZ am Alfried Krupp-Krankenhaus, Essen, Deutschland. , PZ Rhein-Ruhr, Oberhausen, Deutschland. , PZ der UCM, Planegg, Deutschland. , PZ Elbe-Weser, Stade, Deutschland. , PZ Emscher-Lippe, Gladbeck, Deutschland. , PZ Mainspitze, Rüsselsheim, Deutschland. , Euro-Prostatazentrum Aachen, Aachen, Deutschland.